clofazimine

Number of resources: 23

Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient.

 
Barot RK, Viswanath V, Pattiwar MS, Torsekar RG. Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient. Indian J Ophthalmol. 2011;59(4):328-9.

Minocycline is Effective and Cosmetically Preferred to Clofazomine by Leprosy Patients in New York

 
Levis WR, Spencer TI, Ladizinski B. Minocycline is Effective and Cosmetically Preferred to Clofazomine by Leprosy Patients in New York. Journal of Drugs in Dermatology. 2010;9(8):1 p.

Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.

 
Levis WR, Spencer TI, Ladizinski B. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York. J Drugs Dermatol. 2010;9(8):906.

[Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy]

 
Rodríguez G, Pinto R, López F, Gómez Y. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy]. Biomedica. 2009;29(1):18-24.

Use of clofazimine in dermatology.

 
Gurfinkel P, Pina JC, Ramos-E-Silva M. Use of clofazimine in dermatology. J Drugs Dermatol. 2009;8(9):846-51.

Does clofazimine (B663) reach Mycobacterium leprae persisting in Schwann cells and endothelial cells of endoneurial blood vessels in peripheral nerves?

 
Kumar V. Does clofazimine (B663) reach Mycobacterium leprae persisting in Schwann cells and endothelial cells of endoneurial blood vessels in peripheral nerves? Microsc Res Tech. 2008;71(8):614-8.

Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.

 
Goulart IM, Reis AC, De Rezende TM, Borges AS, Ferreira MS, Nishioka SA. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy. Lepr Rev. 2005;76(2):167-9.

[Clofazimine. Current status of therapy with clofazimine (Lampren) for leprosy, erythema leprosum , and other dermatoses after donation of the medicine to the WHO by Novartis]

 
Sunderkötter CH, Lan Ma H. [Clofazimine. Current status of therapy with clofazimine (Lampren) for leprosy, erythema leprosum , and other dermatoses after donation of the medicine to the WHO by Novartis]. Hautarzt. 2005;56(5):478-9.

Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.

 
Pais AV, Pereira S, Garg I, Stephen J, Antony M, Inchara YK. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon. Lepr Rev. 2004;75(2):171-6.

Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine.

 
Schreuder PA, Naafs B. Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine. Lepr Rev. 2003;74(4):386-9.

Determination of clofazimine in leprosy patients by high-performance liquid chromatography.

 
Queiroz RH, Pereira RC, Gotardo MA, Cordeiro DS, Melchior E. Determination of clofazimine in leprosy patients by high-performance liquid chromatography. J Anal Toxicol. 2003;27(6):377-80.

Biochemical and hematological side effects of clofazimine in leprosy patients.

 
Queiroz RH, de Souza AM, Sampaio SV, Melchior E. Biochemical and hematological side effects of clofazimine in leprosy patients. Pharmacol Res. 2002;46(2):191-4.

Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient.

 
Sukpanichnant S, Hargrove NS, Kachintorn U, Manatsathit S, Chanchairujira T, Siritanaratkul N, et al. Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient. Am J Surg Pathol. 2000;24(1):129-35.

Chemotherapy trial in paucibacillary leprosy using clofazimine.

 
Katoch K, Natarajan M, Katoch VM, Singh HB, Bhatia AS. Chemotherapy trial in paucibacillary leprosy using clofazimine. Indian J Lepr. 1999;71(3):311-24.

Resolution of lepromatous leprosy after a short course of amoxicillin/clavulanic acid, followed by ofloxacin and clofazimine.

 
Villahermosa LG, Walsh DS, Fajardo TT, Abalos RM, dela Cruz EC, Veerasubramanian P, et al. Resolution of lepromatous leprosy after a short course of amoxicillin/clavulanic acid, followed by ofloxacin and clofazimine. Int J Dermatol. 1999;38(7):558-60.

Clofazimine therapy for lepromatous leprosy: a historical perspective.

 
Fajardo TT, Abalos RM, dela Cruz EC, Villahermosa LG, Walsh DS, Cellona RV, et al. Clofazimine therapy for lepromatous leprosy: a historical perspective. Int J Dermatol. 1999;38(1):70-4.

Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine.

 
Leiker DL. Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine. Lepr Rev. 1986;57 Suppl 3:272-3.
Syndicate content